NCT00470106

Brief Summary

Veterans with schizophrenia and schizoaffective disorder experience very high levels of disability and poor community outcome. Further improvements in community outcome for patients with these disorders will not occur simply through better control of clinical symptoms. Instead, it will be necessary to find treatments that address the key determinants of poor functional outcome. Evidence strongly suggests that basic (non-social) cognitive and social cognitive deficits are among the key determinants of functional outcome for these illnesses. The primary goal of this 2-year pilot study is to implement and validate a new remediation program for social cognition that is appropriate for veterans with schizophrenia and schizoaffective disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 7, 2007

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2007

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
6.6 years until next milestone

Results Posted

Study results publicly available

April 22, 2016

Completed
Last Updated

April 22, 2016

Status Verified

March 1, 2016

Enrollment Period

2 years

First QC Date

May 4, 2007

Results QC Date

October 14, 2015

Last Update Submit

March 22, 2016

Conditions

Keywords

CognitionRemediationSchizophreniaSocial Cognition

Outcome Measures

Primary Outcomes (1)

  • Mean Test Scores for Facial Emotion Identification.

    This is a test of social cognition that measures the ability to identify the emotion shown in photos of still faces. The construct of interest is facial affect perception. It is an experimental measure and does not have norms or cut-offs. The range of accuracy scores is 0-56 with higher being better.

    Assessments for end point (12 weeks).

Secondary Outcomes (1)

  • Mean Test Score From a Test of Functional Capacity (Ability to Perform Daily Activities).

    Assessments at endpoint (12 weeks).

Study Arms (4)

Cognitive Remediation

ACTIVE COMPARATOR

cognitive remediation

Behavioral: Cognitive remediation

Social Cognitive Skills Training

EXPERIMENTAL

social cognitive skills training

Behavioral: Social Cognitive skills training

Hybrid Intervention

ACTIVE COMPARATOR

combined social cognitive and cognitive remediation training

Behavioral: hybrid intervention

Skills Training

OTHER

control training

Behavioral: skills training

Interventions

Computer exercises in attention, memory, and speed of processing.

Cognitive Remediation

Group training on emotion perception, social perception, and understanding others' mental states.

Social Cognitive Skills Training

A combination of the two groups listed above.

Hybrid Intervention
skills trainingBEHAVIORAL

Skills training in how to identify symptoms of illness and medication side effects.

Skills Training

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All patients must be diagnosed with Schizophrenia, Schizoaffective Disorder, or Psychosis not otherwise specified according to Diagnosis and Statistical Manual-IV criteria.
  • In addition, the subjects will meet the following criteria:
  • Between 18 and 60 years of age
  • Estimated premorbid intelligence quotient \> 70 (based on reading ability)
  • Understand spoken English sufficiently to comprehend testing procedures
  • Clinically stable (e.g., no inpatient hospitalization in the 8 weeks prior to enrollment, no significant changes in medication in the 6 weeks prior to enrollment, and none anticipated for the 3 months of participation)

You may not qualify if:

  • No clinically significant neurological disease as determined by medical history
  • No history of serious head injury (e.g., loss of consciousness longer than 1 hour)
  • No physical, cognitive, or language impairment of such severity as to adversely affect the validity of data
  • No evidence of drug or alcohol dependence in the past six months, and not intoxicated at time of testing
  • The patients psychotic experiences can be explained solely by the use of drugs or alcohol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

West Los Angeles, California, 90073, United States

Location

Related Publications (1)

  • Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M, Marder SR, Green MF. Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res. 2011 Aug;45(8):1113-22. doi: 10.1016/j.jpsychires.2011.01.015. Epub 2011 Mar 4.

MeSH Terms

Conditions

Psychotic DisordersSchizophrenia

Interventions

Cognitive Remediation

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Michael F. Green, PhD
Organization
VA Greater Los Angeles

Study Officials

  • Michael F Green, PhD

    VA Greater Los Angeles Healthcare System, West Los Angeles, CA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2007

First Posted

May 7, 2007

Study Start

September 1, 2007

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

April 22, 2016

Results First Posted

April 22, 2016

Record last verified: 2016-03

Locations